Multiplex ligation-dependent probe amplification versus multiprobe fluorescence in Situ hybridization to detect genomic aberrations in chronic lymphocytic leukemia: A tertiary center experience

Journal of Molecular Diagnostics

Volumn 12, Issue 2, 2010, Pages 197-203

  Al Zaabi, Eiman A ^a   Fernandez, Louis A ^a   Sadek, Irene A ^a   Riddell, D Christie ^a   Greer, Wenda L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATM GENE; CDKN2D GENE; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 19P; CHROMOSOME DELETION; CHROMOSOME DELETION 13; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LDLR GENE; MAJOR CLINICAL STUDY; MALE; MEDICAL TECHNOLOGY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; SENSITIVITY AND SPECIFICITY; TRISOMY 12;

EID: 77649123387     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2010.090046     Document Type: Article

References (30)

1. Richard Lee G, Foerster J: Chronic lymphocytic leukemia. Wintrobe's Clinical Hematology, ed 10. Edited by Maxwell MW, Foerster J, Lukens J, Paraskevas F, John PG, Rodgers GM. Lippincott Williams & Wilkins, 1999, p 2415
2. Dighiero G: CLL biology and prognosis. Hematology Am Soc Hematol Educ Program 2005: 278-284
3. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS: Clinical staging of chronic lymphocytic leukemia. Blood 1975, 46:219-234
4. Boyd K, Dearden CE: Alemtuzumab in the treatment of chronic lymphocytic lymphoma. Expert Rev Anticancer Ther 2008, 8:525-533
5. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK: Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94:1848-1854
6. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N: Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-1847
7. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, Döhner K, Bentz M, Lichter P: Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000, 343:1910-1916
8. Dicker F, Schnittger S, Haferlach T, Kern W, Schoch C: Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression. Blood 2006, 108:3152-3160
9. Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T: Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 2007, 21:2442-2451
10. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002, 30:e57
11. Buijs A, Krijtenburg PJ, Meijer E: Detection of risk-identifying chromosomal abnormalities and genomic profiling by multiplex ligationdependent probe amplification in chronic lymphocytic leukemia. Haematologica 2006, 91:1434-1435
12. Coll-Mulet L, Santidrian AF, Cosialls AM, Iglesias-Serret D, de Frias M, Grau J, Menoyo A, Gonzalez-Barca E, Pons G, Domingo A, and Gil J: Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia. Br J Haematol 2008, 142:793-801
13. National Cancer Institute: Surveillance Epidemiology and End Results (SEER) Cancer Statistics Review 1975-2001, US National Institutes of Health, 2001
14. Omoti CE, Awodu OA, Bazuaye GN: Chronic lymphoid leukaemia: clinico-haematological correlation and outcome in a single institution in Niger Delta region of Nigeria. Int J Lab Hematol 2007, 29:426-432
15. Dighiero G, Maloum K, Desablens B, Cazin B, Navarro M, Leblay R, Leporrier M, Jaubert J, Lepeu G, Dreyfus B, Binet JL, Travade P: Chlorambucil in indolent chronic lymphocytic leukemia: French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med 1998, 338:1506-1514
16. Dewald GW, Brockman SR, Paternoster SF, Bone ND, O'Fallon JR, Allmer C, James CD, Jelinek DF, Tschumper RC, Hanson CA, Pruthi RK, Witzig TE, Call TG, Kay NE: Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol 2003, 121:287-295
17. Bacher U, Kern W, Schoch C, Hiddemann W, Haferlach T: Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH). Ann Hematol 2004, 83:349-355
18. Reddy KS, Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel. Br J Haematol 2006; 132: 705-722
19. Glassman AB, Hayes KJ: The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2005, 158:88-91
20. Goorha S, Glenn MJ, Drozd-Borysiuk E, Chen Z: A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia. Genet Med 2004, 6:48-53
21. Vorstman JA, Jalali GR, Rappaport EF, Hacker AM, Scott C, Emanuel BS: MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum Mutat 2006, 27:814-821
22. Moerland E, van Hezik RL, van der Aa TC, van Beek MW, van den Brule AJ: Detection of HER2 amplification in breast carcinomas: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH) combined with automated spot counting. Cell Oncol 2006, 28:151-159
23. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99:15524-15529
24. Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN: Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 2008, 68:1012-1021
25. Calin GA, Croce CM: Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Semin Oncol 2006, 33:167-173
26. Korz C, Pscherer A, Benner A, Mertens D, Schaffner C, Leupolt E, Döhner H, Stilgenbauer S, Lichter P: Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 2002, 99:4554-4561
27. Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, Kestler HA, Haslinger C, Stilgenbauer S, Döhner H, Bentz M, Lichter P: Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 2004, 101:1039-1044
28. Juliusson G, Gahrton G, Oscier, Fitchett M, Ross F, Brito-Babapulle V, Catovsky D, Knuutila S, Elonen E, Lechleitner M, Tanzer J, Schoenwald M, Castoldi GL, Cuneo A, Nowell P, Peterson L, Kay N: Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia: Second IWCCLL compilation of data on 662 patients. Leukemia Lymphoma 1991, 5(Suppl 1):21-25
29. Takata M, Suzuki T, Ansai S, Kimura T, Shirasaki F, Hatta N, Saida T: Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): its usefulness as an adjunctive diagnostic tool for melanocytic tumors. J Dermatol Sci 2005, 40:51-57
30. Slater H, Bruno D, Ren H, La P, Burgess T, Hills L, Nouri S, Schouten J, Choo KH: Improved testing for CMT1A and HNPP using multiplex ligation-dependent probe amplification (MLPA) with rapid DNA preparations: comparison with the interphase FISH method. Hum Mutat 2004, 24:164-171